Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertrophic Cardiomyopathy”

377 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 377 results

Not applicableLooking for participantsNCT06610019
What this trial is testing

Cardiovascular Multimodality Imaging Study

Who this might be right for
Non-ischemic CardiomyopathyCardiomyopathiesHypertrophic Cardiomyopathy+7 more
Montefiore Medical Center 5,000
Early research (Phase 1)Study completedNCT05719805
What this trial is testing

Evaluate the Effects of Mavacamten in Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 84
Not applicableLooking for participantsNCT06935253
What this trial is testing

Large Language Models To Improve the Quality of Care of Cardiology Patients

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)CardiomyopathyGenetic Disease+1 more
Stanford University 12
Not applicableLooking for participantsNCT07103057
What this trial is testing

VIZ ACCESS HCM - Multi-Site Registry

Who this might be right for
Hypertrophic Cardiomyopathy
Viz.ai, Inc. 500
Post-approval studies (Phase 4)Not Yet RecruitingNCT07103655
What this trial is testing

The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
Second Affiliated Hospital, School of Medicine, Zhejiang University 132
Post-approval studies (Phase 4)Looking for participantsNCT06401343
What this trial is testing

Use of SGLT2i in noHCM With HFpEF

Who this might be right for
Hypertrophic CardiomyopathyHeart Failure With Preserved Ejection Fraction
China National Center for Cardiovascular Diseases 94
Not applicableUnknownNCT06169358
What this trial is testing

Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy

Who this might be right for
Hypertrophic CardiomyopathyLeft Ventricular HypertrophyFabry Disease
Qilu Hospital of Shandong University 627
Not applicableLooking for participantsNCT05610215
What this trial is testing

Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy

Who this might be right for
Atrial FibrillationCardiomyopathy, HypertrophicRadiofrequency Ablation
China National Center for Cardiovascular Diseases 66
Not applicableLooking for participantsNCT02432092
What this trial is testing

Pediatric Cardiomyopathy Mutation Analysis

Who this might be right for
CardiomyopathiesDilated CardiomyopathyHypertrophic Cardiomyopathy+3 more
Indiana University 300
Early research (Phase 1)Study completedNCT05135871
What this trial is testing

Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects

Who this might be right for
Hypertrophic Cardiomyopathy
LianBio LLC 45
Not applicableLooking for participantsNCT07006493
What this trial is testing

REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy, Obstructive
SuZhou Sinus Medical Technologies Co.,Ltd 124
Testing effectiveness (Phase 2)UnknownNCT00430833
What this trial is testing

CHANCE - Candesartan in Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Charles University, Czech Republic
Early research (Phase 1)UnknownNCT06210607
What this trial is testing

A Trial of HS-10511 in Healthy Subjects

Who this might be right for
Hypertrophic Cardiomyopathy
Jiangsu Hansoh Pharmaceutical Co., Ltd. 96
Post-approval studies (Phase 4)Study completedNCT01721967
What this trial is testing

Ranolazine for the Treatment of Chest Pain in HCM Patients

Who this might be right for
Hypertrophic Cardiomyopathy
Duke University 14
Testing effectiveness (Phase 2)Looking for participantsNCT06092034
What this trial is testing

A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

Who this might be right for
Danon Disease
Rocket Pharmaceuticals Inc. 14
Testing effectiveness (Phase 2)Study completedNCT01643330
What this trial is testing

Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Who this might be right for
Ischemic CardiomyopathyNon-ischemic CardiomyopathyHeart Failure+1 more
Celladon Corporation 250
Not applicableUnknownNCT05577208
What this trial is testing

Renal Denervation in Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Adolfo Fontenla 20
Not applicableEnded earlyNCT06775886
What this trial is testing

Effect of Personalized Accelerated Pacing in Symptomatic Patients With Non-Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Non-obstructive Hypertrophic CardiomyopathyHypertrophic Cardiomyopathy
Montefiore Medical Center 1
Early research (Phase 1)Study completedNCT00001396
What this trial is testing

Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop...

Who this might be right for
Hypertrophic Cardiomyopathy
National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableLooking for participantsNCT07150299
What this trial is testing

Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy \(HOCM\)
Medical University of Vienna 20
Load More Results